| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.deshrakshak.in | |
| Market Cap | 3.24 Cr. | |
| Enterprise Value(EV) | 7.43 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.96 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 7.61 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 42.14 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 20.70 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 0.35 | Calculated using Price: 7.29 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.44 Cr. | 4,438,324 Shares |
| FaceValue | 10 | |
| About Desh Rakshak Aushdhalaya Ltd. | ||
| The company is the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by its Ancient Seers & Sages. The medicines are categorized into Patent & Proprietary (Classical) Medicines. The company is currently manufacturing around 400 products (Patent and Classical mix). And all these medicines are manufactured as per the prescribed norms and standards of the Indian Government. | ||
| 1 Day |
|
|
| 1 Week |
|
|
| 1 Month |
|
+4.89% |
| 3 Month |
|
+4.89% |
| 6 Month |
|
+21.30% |
| 1 Year |
|
+33.52% |
| 2 Year |
|
+69.53% |
| 5 Year |
|
+78.24% |
| 10 Year |
|
-16.21% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.37 | 4.36 | 4.03 | 3.9 | 4.4 | 3.83 | 5.05 | 5.49 | 4.54 | |
| Return on Capital Employed (%) | 2.54 | 5.98 | 5.33 | 5.54 | 5.99 | 5.77 | 6.69 | 6.44 | 6.7 | |
| Return on Assets (%) | 0.26 | 2.96 | 2.78 | 2.69 | 3.01 | 2.56 | 3.12 | 3.13 | 2.54 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | |
| Non Curr. Liab. | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | 4 | |
| Curr. Liab. | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 10 | 10 | 10 | 11 | 11 | 12 | 15 | 16 | 16 | 16 | |
| Non Curr. Assets | 5 | 6 | 6 | 7 | 7 | 8 | 9 | 11 | 11 | 10 | |
| Curr. Assets | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | 5 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 10 | 10 | 10 | 11 | 11 | 12 | 15 | 16 | 16 | 16 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 4 | 5 | 5 | 5 | 6 | 5 | 7 | 6 | 6 | 5 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total Income | 4 | 5 | 5 | 5 | 6 | 5 | 7 | 6 | 6 | 5 | |
| Total Expenditure | -4 | -4 | -4 | -4 | -5 | -4 | -6 | -5 | -5 | -4 | |
| PBIDT | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Adjusted EPS | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 1 | 0 | 0 | -1 | 1 | 1 | 0 | 0 | |
| Cash Fr. Inv. | 0 | 0 | -1 | -1 | 0 | 0 | -1 | -1 | -2 | -1 | |
| Cash Fr. Finan. | 0 | 1 | 1 | 1 | 0 | ||||||
| Net Change | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
|
Mon, 29 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Sohini Bansal Designation: Company Secretary EmailId: cssohinibansal@gmail.com Name of the Chief Financial Officer: Amit Kumar Singh Designation: Chief Financial Officer EmailId: amitdral96@gmail.com Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Mon, 29 Apr 2024
Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. For The Quarter Ended As On 31St March 2024. We herein provide Statement of Deviation or Variation in Public Issue Rights Issue Preferential Issue Etc. pursuant to Regulation 32 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 |
|||||||||||||||||||||
|
Thu, 25 Apr 2024
Compliance Certificate Pursuant To Regulation 40(9) And 40 (10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31.03.2024 We have enclosed the compliance Certificate pursuant to Regulation 40(9) and 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on 31.03.2024 |
|
No Scans Found |
